# SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt

> **NCT06588179** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 58 (estimated)

## Conditions studied

- NMIBC

## Interventions

- **DRUG:** SHR-1501+SHR-2005

## Key facts

- **NCT ID:** NCT06588179
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2027-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06588179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06588179, "SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06588179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*